Company Filing History:
Years Active: 2003-2006
Title: Michael P. Reilly: Innovator in Lung Volume Reduction Technologies
Introduction
Michael P. Reilly is a notable inventor based in Southlake, TX (US), recognized for his contributions to medical technology, particularly in the field of pulmonary health. He holds 2 patents that focus on innovative methods for lung volume reduction, which are crucial for patients suffering from chronic obstructive pulmonary disease and other related conditions.
Latest Patents
Reilly's latest patents include "Methods and devices for obstructing and aspirating lung tissue segments." This invention provides improved methods, systems, devices, and kits for performing lung volume reduction in patients. The techniques are minimally invasive, utilizing instruments introduced through the mouth (endotracheally) to isolate a target lung tissue segment from other regions of the lung. The isolation is achieved by deploying an obstructive device in a lung passageway leading to the target segment. Once anchored, the segment can be aspirated through the device using various methods, including coupling an aspiration catheter to an inlet port on the obstruction device. The design also allows for a valve that permits gas outflow during expiration while preventing air inflow during inspiration. The obstructive device can remain as an implant for ongoing isolation or be removed as needed.
Career Highlights
Michael P. Reilly is currently associated with Pulmonx Corporation, where he continues to develop and refine technologies aimed at improving patient outcomes in respiratory health. His work is pivotal in advancing minimally invasive procedures that enhance the quality of life for individuals with severe lung conditions.
Collaborations
Reilly collaborates with esteemed colleagues such as Peter P. Soltesz and Robert Kotmel, contributing to a dynamic team focused on innovative solutions in pulmonary medicine.
Conclusion
Michael P. Reilly's work exemplifies the intersection of innovation and healthcare, particularly in the development of techniques that address critical respiratory issues. His contributions are significant in the ongoing effort to improve treatment options for patients with chronic lung diseases.